Search
Search Results
##search.searchResults.foundPlural##
-
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1817PDF: 859HTML: 926jdoe, table 2 infections CML .doc: 253jdoe, table 1 infections CML .doc: 233 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
281PDF: 390Suppl. Files: 79HTML: 187 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3867PDF: 1347HTML: 3957Untitled: 287Untitled: 319 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2667PDF: 1270HTML: 1095 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2661PDF: 1799HTML: 718 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3351PDF: 1429HTML: 4163 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1877PDF: 1258HTML: 359 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1125PDF: 531HTML: 170 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2496PDF: 1079HTML: 1672Fig 1: 256Tab I: 262Cover Letter: 268 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
3564PDF: 930HTML: 1172Cover: 236 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2328PDF: 1058HTML: 1993 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1836PDF: 671HTML: 304 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1076PDF: 575HTML: 344 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3434PDF: 673Suppl. Files: 330HTML: 312 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
110PDF: 199Suppl. Files: 33Html: 117Html Suppl. Files: 94 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
5935PDF: 1098HTML: 490TABLE: 236FIGURES: 324 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3339PDF: 1185HTML: 1995 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3720PDF: 1291HTML: 523 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1822PDF: 678HTML: 1562Figure 1: MRI demonstrating Aspergillus synovitis: 231Figure 2:MRI demonstrating Aspergillus synovitis: 240 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3948PDF: 1677HTML: 8256Randi Fig: 234 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1600PDF: 918HTML: 1119Untitled: 224 -
How I treat acute and persistent sickle cell pain
2137PDF: 1194HTML: 800 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2231PDF: 1390HTML: 3518







